Elevage Medical Technologies

Venture capital firm

We track Elevage Medical Technologies but have little verified detail yet.

At a glance

Elevage Medical Technologies appears in 2 funding rounds tracked by ValueAddVC since 2025, leading 1. Its most recent tracked deal was Elucid's $55M Series D round (Sep 4, 2026).

Portfolio

2 total

Recent Investment Activity

2

Track record: led 1 and participated in 1 of 2 tracked venture rounds · 2 in the last 12 months · led 1 Series B

DateCompanyEventRoleAmountValuationInvestorsSource
Sep 4, 2026ElucidSeries DParticipated$55M—Pulse story
Dec 30, 2025BiobeatSeries BLed$50M—Refresh Miami

Sector / Stage Activity

By sector (portfolio)
Medtech / cuff-less blood pressure monitoring
1 · 50%
Biotech
1 · 50%
By stage (tracked rounds)
Series D
1 · 50%
Series B
1 · 50%

Co-Investors

1

Latest Pulse

  1. Elucid Raises $55M for AI Heart-Disease ImagingBoston-based Elucid raised $55 million in an oversubscribed Series D to expand its FDA-cleared Plaque-IQ software, which uses AI to read plaque risk from routine CT scans.→

Elevage Medical Technologies FAQ

What companies has Elevage Medical Technologies invested in?

Elevage Medical Technologies' portfolio includes Elucid, Biobeat.

Who does Elevage Medical Technologies co-invest with most?

In the rounds Value Add tracks, Elevage Medical Technologies most often invests alongside OrbiMed Advisors (1 shared deal).

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction